Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer.
Yugo KaiKenji IkezawaRyoji TakadaKazuma DaikuShingo MaedaYutaro AbeTakuo YamaiNobuyasu FukutakeTasuku NakaboriHiroyuki UeharaShigenori NagataHiroshi WadaKazuyoshi OhkawaPublished in: JGH open : an open access journal of gastroenterology and hepatology (2021)
MSI examinations in BTC were successful in almost all cases, regardless of tissue sampling methods. We experienced a case in which pembrolizumab resulted in a complete response to MSI-H BTC. Since pembrolizumab for MSI-H BTC could prolong survival time, MSI examination should be performed proactively to increase treatment options.